Lv41
587 积分 2021-02-19 加入
The pathogenesis of systemic manifestations in Sjögren disease
3天前
已完结
The APLAR Recommendations for the Management of Psoriatic Arthritis
14天前
已完结
Efficacy of Ruxolitinib in Patients with Hemophagocytic Lymphohistiocytosis: A Systematic Review
14天前
已关闭
Infection, inflammation and immune dysregulation: evolving perspectives on the host response
14天前
已完结
Monoclonal gammopathy of clinical significance: what the rheumatologist needs to know
21天前
已完结
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
2个月前
已完结
Tirzepatide monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO)
2个月前
已完结
Efficacy and safety of tirzepatide added to basal insulin in patients with type 2 diabetes in China (SURPASS-CN-INS): a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
[Expert consensus on the assessment, diagnosis, and management of cardiovascular-kidney-metabolic syndrome]
2个月前
已完结
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
2个月前
已完结